BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5. Tartof SY, Slezak JM, Puzniak L, Hong V, et al. Lancet Infect Dis 2022 Oct 25. pii: S1473-3099(22)00692.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tartof SY, Slezak JM, Puzniak L, Hong V, et al. BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5. Lancet Infect Dis 2022 Oct 25. pii: S1473-3099(22)00692.
PMID: 36306800